Condition
Diabetes With Diabetic Autonomic Neuropathy (Diagnosis) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Diabetes With Diabetic Autonomic Neuropathy (Diagnosis) clinical trials that are recruiting, in China. By phase: Phase 4 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
GLP-1 receptor agonists for diabetic cardiac autonomic neuropathy in type 2 diabetes
This study will try once-weekly semaglutide or polyethylene glycol loxenatide plus usual care to see if they improve heart nerve function in adults with type 2 diabetes who have diabetic cardiac autonomic neuropathy.
-
Effects of GLP-1RA on heart health in diabetes patients
This study is testing if a diabetes medication called Semaglutide can improve heart health and symptoms related to heart issues in people with type 2 diabetes.
Related topics
Quick answers
How many Diabetes With Diabetic Autonomic Neuropathy (Diagnosis) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.